MAPT and Alzheimer disease: To establish a connection between developmental Pb exposure and AD risk, we characterized changes in well-established pathological hallmarks of AD, namely, phosphorylated tau, beta-amyloid (Aβ) peptide, and tau aggregates formed by hyperphosphorylated tau (64, 65).